Afya Announces Changes to Its Board of Directors
July 01 2024 - 9:35AM
Business Wire
Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the
“Company”), the leading medical education group and medical
practice solutions provider in Brazil, announced today that Mrs.
Shobhna Mohn notified the Company of her intent to resign as a
member of the Board of Directors of the Company, effective as of
June 30, 2024, as she also steps down from her operational role at
Bertelsmann, one of the key shareholders of Afya. Mrs. Mohn's
decision is unrelated to any matter associated with the Company,
its operations, policies, or practices.
During her tenure as a member of the Board of Directors, Mrs.
Mohn has made significant and valuable contributions to the
Company, supporting its journey towards becoming Brazil's leading
medical education group and medical practice solutions provider.
Her insights and dedication have been instrumental in our growth
and success.
"As CEO, I sincerely thank Mrs. Mohn for her invaluable
contributions and solid dedication to our Company. Her strategic
insights and leadership have been fundamental in our growth and
success. We wish her all the best in her future endeavors and
remain grateful for her lasting impact on our organization," said
Virgilio Gibbon, Afya’s CEO.
Shobhna Mohn mentioned: “It has been a privilege and an honor to
be part of building Afya, working with some of the best investors,
board members and management in the industry, seeing it list on
Nasdaq in 2019, and becoming an industry reference in a key and
impactful sector while spearheading innovation. For me personally,
it was a great way to get introduction to the Brazilian Market with
exemplary structures when it comes to quality medical education. I
wish everyone in the Board and Management continued success and
impact and will certainly miss our regular exchanges.”
Afya, also announces that there are no immediate plans for
Bertelsmann SE&Co. KGaA to appoint a new member to fill her
position on the Board of Directors. Afya remains steadfast in its
commitment to maintaining a strong and effective board with the
requisite skills and experience to guide the company forward and
ensure our continued success.
Afya’s Board of Directors is composed of two co-chairmen - one
representing Bertelsmann SE&Co. KGaA, and one representing the
Esteves family - two more members of Bertelsmann SE&Co. KGaA,
one more member of the Esteves family, one member from Softbank and
four independent members, resulting in a diversity of skills and
experience to enhance Afya’s decision-making:
BOARD OF DIRECTORS Name Office Nicolau Carvalho Esteves
Co-Chairman of the Board Kay Krafft Co-Chairman of the Board
Benedikt Dalkmann Director Christina Krebs Director Renato Tavares
Esteves Director Maria Tereza Azevedo Director João Paulo Seibel de
Faria Independent Director Vanessa Claro Lopes Independent Director
Miguel Filisbino Pereira de Paula Independent Director Marcelo Ken
Suhara Independent Director
About Afya Limited (Nasdaq: AFYA, B3: A2FY34)
Afya is a leading medical education group in Brazil based on the
number of medical school seats, delivering an end-to-end
physician-centric ecosystem that serves and empowers students and
physicians to transform their ambitions into rewarding lifelong
experiences from the moment they join us as medical students
through their medical residency preparation, graduation program,
continuing medical education activities and offering medical
practice solutions to help doctors enhance their healthcare
services through their whole career.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240701202967/en/
Investor Contact: ir@afya.com.br IR
Website: ir.afya.com.br
Media Contact: Cíntia Moraes Marin
cintia.marin@afya.com.br
Afya (NASDAQ:AFYA)
Historical Stock Chart
From Oct 2024 to Nov 2024
Afya (NASDAQ:AFYA)
Historical Stock Chart
From Nov 2023 to Nov 2024